CYP3A4 and metabolic dysfunction-associated steatotic liver disease: Enzymatic activity and mRNA expression of CYP3A4 are low in patients with nonalcoholic fatty liver disease, and this observation is confirmed by experiments on mice in vivo and on cultured cells in vitro [284,285,286,287,288,289].